Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer

ErbB2 is a type of receptor tyrosine kinase, which is known to be involved in tumorigenesis, tumor aggressiveness, and clinical outcome. ErbB2-targeting therapy using therapeutic antibodies has been successful in breast cancer treatment. However, the need for repeated treatments and the high cost ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Sho, Kim, Min Woo, Lee, Gibok, Park, Yong Il, Niidome, Takuro, Lee, Ruda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356551/
https://www.ncbi.nlm.nih.gov/pubmed/32599712
http://dx.doi.org/10.3390/pharmaceutics12060585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356551/
https://www.ncbi.nlm.nih.gov/pubmed/32599712
http://dx.doi.org/10.3390/pharmaceutics12060585

Ejemplares similares